Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users

NCT04091243 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER_GOV

Sponsor class

Conditions

Glucocorticoid-induced Osteoporosis

Interventions

DRUG: Romosozumab

Sponsor

Tuen Mun Hospital